Cervical cancer trials in Czechia
7 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
- Where
- Brno-Stred, Nový Jičín, Ostrava, Prague
- Age
- 18 years and over
- People
- 1,023 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07216703 · EU 2025-521514-26-00 - No phaseTaking peopleRole of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring
- Where
- Olomouc
- Age
- 18 years to 99 years
- People
- 480
- Run by
- The Institute of Molecular and Translational Medicine, Czech Republic
See details and how to joinNCT05774561 - Phase 3Taking peoplePARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
- Where
- Ostrava, Pilsen, Prague
- Age
- 18 years and over
- People
- 510 worldwide
- Run by
- Institut Claudius Regaud
See details and how to joinNCT05581121 - No phaseTaking peopleHPV After chemoRadioTherapy
- Where
- Prague
- Age
- 18 years and over
- People
- 120
- Run by
- General University Hospital, Prague
See details and how to joinNCT07493928 - No phaseTaking peopleSelf-sampling for Non-attenders to Cervical Cancer Screening
- Where
- Olomouc
- Age
- 30 years to 65 years
- People
- 15,000
- Run by
- The Institute of Molecular and Translational Medicine, Czech Republic
See details and how to joinNCT04226313 - No phaseTaking peopleEpidemiological Factors and Optimization of Conservative Approaches to Precancerous Lesions of Female Reproductive Organs
- Where
- Prague
- Age
- 18 years to 46 years
- People
- 200
- Run by
- Nikola Janovska
See details and how to joinNCT06967740 - Phase 3Taking peopleIntermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy
- Where
- České Budějovice, Hradec Králové, Ostrava, Plzen 23, Prague, Prague 2
- Age
- 18 years to 85 years
- People
- 514 worldwide
- Run by
- The Central and Eastern European Gynecologic Oncology Group
See details and how to joinNCT04989647 · EU 2023-504973-19-01